Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

BACKGROUND: To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients. MATERIALS AND METHODS: Endpoints of the analysis were: (a) treatment discontinuation of RPV/FTC/TDF for any reasons and (b) o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Int AIDS Soc
Главные авторы: Pinnetti, Carmela, Di Giambenedetto, Simona, Maggiolo, Franco, Lorenzini, Patrizia, Fabbiani, Massimiliano, Tommasi, Chiara, Latini, Alessandra, Ammassari, Adriana, Loiacono, Laura, Sterrantino, Gaetana, Bellagamba, Rita, Boumis, Evangelo, Antinori, Andrea, Zaccarelli, Mauro
Формат: Artigo
Язык:Inglês
Опубликовано: International AIDS Society 2014
Предметы:
Poster Sessions – Abstract P280
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225448/
https://ncbi.nlm.nih.gov/pubmed/25397556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19812
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы